Heba Azouz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heba Azouz has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A. Khadhar
Service d'Anatomie Pathologique, Hôpital la Rabta, Tunis, Tunisie
1 shared publicationAbenezer Tirsit
Addis Ababa University Neurosurgery Division, Department of Surgery Addis Ababa , Ethiopia
1 shared publicationAhmed El-Said Ahmed
Department of Neurosurgery, Faculty of Medicine, Cairo University, Cairo, Egypt
1 shared publicationAkano Lordstrong
University of Ibadan College of Medicine Ibadan , Nigeria
1 shared publication- Ali Awadallah Saeed
The Mycetoma Research Center, University of Khartoum, Khartoum, Sudan
1 shared publication - Alia Zehani
Service d'Anatomie Pathologique, Hôpital la Rabta, Tunis, Tunisie
1 shared publication
Latest Publications
- 25 February 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-11
Corpus callosotomy for intractable epilepsy in the pediatric population: value of intraoperative neurophysiological monitoring
Background Intraoperative neuromonitoring (IONM) is utilized in many neurosurgical procedures. It is often employed when operating in close proximity to eloquent regions as it can delineate such areas from the targeted resection. IONM can additionally provide surgeon assurance and confidence in chosen intraoperative maneuvers. However, there is no clear consensus regarding whether it provides significant value in pediatric corpus callosotomy. This study reviews the current literature to evaluate intraoperative utility, prognostic value, and medicolegal considerations of IONM in pediatric corpus callosotomy. Methods An extensive literature review was performed through PubMed, OVID Medline, SCOPUS, and Embase. Reference lists were manually screened to identify additional applicable articles. Studies were evaluated qualitatively for inclusion and reported descriptively. Results The search strategy yielded 1523 articles. Following duplicate removal, initial screening, and full-text review, 8 were included. Both disruption of bisynchronous epileptiform discharges (EDs) and lateralization of previously generalized EDs have been proposed as having a prognostic value in callosotomy. No significant correlation between intraoperative ED changes and seizure outcomes has been found in the studies evaluated here. Guidance of posterior dissection extent has also been suggested to be of intraoperative utility in callosotomy. Given that the majority of corpus callosotomies in the pediatric population are complete as opposed to an anterior two-thirds technique, the overall utility in dissection guidance is low. Conclusion IONM has not been found to provide significant prognostic value nor strongly contribute to improving surgical outcomes during corpus callosotomies for pediatric patients with intractable epilepsy. Medicolegal considerations across the field of neurosurgery have grown in recent years; the majority of litigation perspectives are isolated to spine surgery, with IONM functioning more for documentation purposes in pediatric corpus callosotomy. The use of IONM during pediatric corpus callosotomy remains the surgeon’s preference as it has not been defined as the standard of care.
- 25 February 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-11
Corpus callosotomy for intractable epilepsy in the pediatric population: value of intraoperative neurophysiological monitoring
Background Intraoperative neuromonitoring (IONM) is utilized in many neurosurgical procedures. It is often employed when operating in close proximity to eloquent regions as it can delineate such areas from the targeted resection. IONM can additionally provide surgeon assurance and confidence in chosen intraoperative maneuvers. However, there is no clear consensus regarding whether it provides significant value in pediatric corpus callosotomy. This study reviews the current literature to evaluate intraoperative utility, prognostic value, and medicolegal considerations of IONM in pediatric corpus callosotomy. Methods An extensive literature review was performed through PubMed, OVID Medline, SCOPUS, and Embase. Reference lists were manually screened to identify additional applicable articles. Studies were evaluated qualitatively for inclusion and reported descriptively. Results The search strategy yielded 1523 articles. Following duplicate removal, initial screening, and full-text review, 8 were included. Both disruption of bisynchronous epileptiform discharges (EDs) and lateralization of previously generalized EDs have been proposed as having a prognostic value in callosotomy. No significant correlation between intraoperative ED changes and seizure outcomes has been found in the studies evaluated here. Guidance of posterior dissection extent has also been suggested to be of intraoperative utility in callosotomy. Given that the majority of corpus callosotomies in the pediatric population are complete as opposed to an anterior two-thirds technique, the overall utility in dissection guidance is low. Conclusion IONM has not been found to provide significant prognostic value nor strongly contribute to improving surgical outcomes during corpus callosotomies for pediatric patients with intractable epilepsy. Medicolegal considerations across the field of neurosurgery have grown in recent years; the majority of litigation perspectives are isolated to spine surgery, with IONM functioning more for documentation purposes in pediatric corpus callosotomy. The use of IONM during pediatric corpus callosotomy remains the surgeon’s preference as it has not been defined as the standard of care.
- Open Access
- 17 July 2023
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 38 (1) , 1-5
Comparative study between the outcome of decompressive craniotomy versus craniectomy in the management of acute subdural hematoma
Background: Acute Subdural hematoma is a very crucial entity in traumatic brain injury, presented with disabling morbid complications and a high mortality rate; therefore, it is a massive socio-economic burden, leading to either direct or secondary brain injury, as hypoxia. Aim and objectives: Comparative study between decompressive craniotomy (DC) and craniectomy in the management of acute subdural and their consequences. Assessing the most effective management protocol for ASDH with the least morbidity, short hospital’ stay and avoidance of re-operation. Method: The study design is a prospective comparative randomized study, conducted on 30 patients with ASDH operated and managed starting December 2019 inclusive April 2021 at the Neurosurgery Department Cairo University Hospitals. They were divided equally into two groups: 15 had decompressive craniectomy and another 15 cases were operated upon with craniotomy. All patients were diagnosed with traumatic ASDH. Results: The mean GCS pre-operative in DC was (9.4) mean with a range from (6 to 13) and the post-operative mean was (11.13) with a range from (4 to 15) compared to the results in the craniotomy group; the pre-operative mean was (9.6) with a range from (6 to 10) and the post-operative GCS mean (11.53) ranging from (6 to 14) that had a P value of 0.69. Conclusion: There is no statistical significance in comparing decompressive craniectomy and craniotomy in dealing with ASDH, yet early time of surgical evacuation and duroplasty have shown to have good prognostic factors.
- 17 July 2023
- Published by Springer Nature in Egyptian Journal of Neurosurgery
- Vol. 38 (1) , 1-5
Open AccessComparative study between the outcome of decompressive craniotomy versus craniectomy in the management of acute subdural hematoma
Background: Acute Subdural hematoma is a very crucial entity in traumatic brain injury, presented with disabling morbid complications and a high mortality rate; therefore, it is a massive socio-economic burden, leading to either direct or secondary brain injury, as hypoxia. Aim and objectives: Comparative study between decompressive craniotomy (DC) and craniectomy in the management of acute subdural and their consequences. Assessing the most effective management protocol for ASDH with the least morbidity, short hospital’ stay and avoidance of re-operation. Method: The study design is a prospective comparative randomized study, conducted on 30 patients with ASDH operated and managed starting December 2019 inclusive April 2021 at the Neurosurgery Department Cairo University Hospitals. They were divided equally into two groups: 15 had decompressive craniectomy and another 15 cases were operated upon with craniotomy. All patients were diagnosed with traumatic ASDH. Results: The mean GCS pre-operative in DC was (9.4) mean with a range from (6 to 13) and the post-operative mean was (11.13) with a range from (4 to 15) compared to the results in the craniotomy group; the pre-operative mean was (9.6) with a range from (6 to 10) and the post-operative GCS mean (11.53) ranging from (6 to 14) that had a P value of 0.69. Conclusion: There is no statistical significance in comparing decompressive craniectomy and craniotomy in dealing with ASDH, yet early time of surgical evacuation and duroplasty have shown to have good prognostic factors.
- Open Access
- 1 July 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Protocols and Research Methodologies
- Vol. 2023 (3)
Assessing the neuroprotective efficacy of atorvastatin in traumatic brain injury: a systematic review protocol
Traumatic brain injury (TBI) is a significant public health threat, with an estimated 5.3 million people in the United States alone living with a disability related to TBI (1). The most common therapies for individuals with TBI at this time include supportive measures, direct monitoring and surgical interventions, but the treatment outcomes following TBI are still poor. Atorvastatin is one of 3-hydroxy–3-methylglutaryl coenzyme A reductase inhibitors commonly used for treatment reduction of low-density lipoprotein and relief of symptoms in cerebrovascular diseases, however, the recent randomized trials in animal models and human subjects have revealed a promising therapeutic effect for its use in the treatment of TBI that has shown a significant alleviation of neurological dysfunctions. Hence, this systematic review will streamline and provide a comprehensive avenue for understanding more about the dynamics of atorvastatin and its neuroprotective efficacy for the treatment of the severity of TBI and the improvement of functional outcomes. This systematic review will follow the 2020 PRISMA guidelines. Information sources will be obtained from electronic databases such as Pubmed, Cochrane Library, EMBASE and SCOPUS. All patients with TBI that received Atorvastatin will be included. The review will also include original peer-reviewed research articles addressing the efficacy of Atorvastatin in TBI in English. Ethical approval will not be required as there will be no human participant involvement in this study. The findings from this study will be disseminated at scientific conferences and published in a reputable peer-reviewed journal.Strengths A wide range of study types will be included increasing the pool of information.Accuracy will be upheld as two to three reviewers will independently screen titles, abstracts and full texts.Limitations Only studies in English will be included, hence studies in other languages that may be very informative will be excluded.
- 1 July 2023
- Published by Oxford University Press (OUP) in Journal of Surgical Protocols and Research Methodologies
- Vol. 2023 (3)
Open AccessAssessing the neuroprotective efficacy of atorvastatin in traumatic brain injury: a systematic review protocol
Traumatic brain injury (TBI) is a significant public health threat, with an estimated 5.3 million people in the United States alone living with a disability related to TBI (1). The most common therapies for individuals with TBI at this time include supportive measures, direct monitoring and surgical interventions, but the treatment outcomes following TBI are still poor. Atorvastatin is one of 3-hydroxy–3-methylglutaryl coenzyme A reductase inhibitors commonly used for treatment reduction of low-density lipoprotein and relief of symptoms in cerebrovascular diseases, however, the recent randomized trials in animal models and human subjects have revealed a promising therapeutic effect for its use in the treatment of TBI that has shown a significant alleviation of neurological dysfunctions. Hence, this systematic review will streamline and provide a comprehensive avenue for understanding more about the dynamics of atorvastatin and its neuroprotective efficacy for the treatment of the severity of TBI and the improvement of functional outcomes. This systematic review will follow the 2020 PRISMA guidelines. Information sources will be obtained from electronic databases such as Pubmed, Cochrane Library, EMBASE and SCOPUS. All patients with TBI that received Atorvastatin will be included. The review will also include original peer-reviewed research articles addressing the efficacy of Atorvastatin in TBI in English. Ethical approval will not be required as there will be no human participant involvement in this study. The findings from this study will be disseminated at scientific conferences and published in a reputable peer-reviewed journal.Strengths A wide range of study types will be included increasing the pool of information.Accuracy will be upheld as two to three reviewers will independently screen titles, abstracts and full texts.Limitations Only studies in English will be included, hence studies in other languages that may be very informative will be excluded.
- 1 May 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (6) , 293-297
À propos d’une tumeur rarissime du rein : la tumeur mixte épithéliale et stromale maligne
- 1 May 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (6) , 293-297
À propos d’une tumeur rarissime du rein : la tumeur mixte épithéliale et stromale maligne